Status:
RECRUITING
Mixed Reality in MitraClip Implantation: Preliminary Case Series
Lead Sponsor:
Nemocnice AGEL Trinec-Podlesi a.s.
Conditions:
Mitral Regurgitation
Eligibility:
All Genders
18+ years
Brief Summary
The study aims to evaluate the impact of mixed reality (MR) technology, particularly using Hololens 2.0 and specialized software for three-dimensional DICOM image visualization, on MitraClip implantat...
Detailed Description
The advent of mixed reality (MR) technology, especially when integrated with Hololens 2.0 and specialized software for three-dimensional DICOM image visualization, offers promising avenues for enhanci...
Eligibility Criteria
Inclusion
- Adults aged over 18 years
- Patients diagnosed with mitral valve regurgitation requiring MitraClip implantation
- Ability to provide informed consent and comply with study procedures
Exclusion
- Patients with contraindications for MR technology (e.g., MRI incompatibility)
- Individuals unable to comply with study procedures due to physical or cognitive impairments
- Pregnant or breastfeeding women
Key Trial Info
Start Date :
August 15 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2026
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT06539416
Start Date
August 15 2024
End Date
December 30 2026
Last Update
January 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital AGEL Trinec-Podlesi a.s.
Třinec, CZ, Czechia, 73961